Medical Scientist Training Program Student Wins ASH Award
Katelyn Melgar, a student in the College of Medicines Medical Scientist Training Program, received a 2015 Minority Graduate Student Abstract Achievement Award from the American Society of Hematology (ASH) and presented her abstract, titled "Novel Small Molecule FLT3 Inhibitors for the Treatment of FLT3-ITD AML, at the 57th ASH annual meeting Dec. 5-8 in Orlando.
Each year, ASH offers these awards, which are merit-based, to select graduate students to acknowledge the accomplishments of and retain minority graduate students in the field of hematology through exposure to its annual meeting.
Melgars focus is on immunology, and shes currently in the lab of Daniel Starczynowski, PhD, associate professor in UCs Department of Pediatrics and a researcher in the Division of Experimental Hematology and Cancer Biology at Cincinnati Childrens Hospital Medical Center.
Katelyn Melgar, a student in the College of Medicine s Medical Scientist Training Program, with her winning abstract.
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
UC graduates cross finish line at commencement
August 7, 2026
The University of Cincinnati recognized 2,125 graduates in two ceremonies at summer commencement Friday on campus at Fifth Third Arena.